Linscomb Wealth’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,443
Closed -$210K 300
2024
Q4
$210K Sell
2,443
-650
-21% -$70.3K 0.01% 285
2024
Q3
$368K Sell
3,093
-3,479
-53% -$464K 0.02% 235
2024
Q2
$938K Buy
6,572
+83
+1% +$11K 0.05% 163
2024
Q1
$833K Hold
6,489
0.04% 174
2023
Q4
$671K Buy
6,489
+689
+12% +$68.1K 0.04% 189
2023
Q3
$527K Hold
5,800
0.03% 204
2023
Q2
$469K Hold
5,800
0.03% 216
2023
Q1
$462K Sell
5,800
-2
-0% -$142 0.02% 218
2022
Q4
$393K Buy
5,802
+2
+0% +$117 0.02% 250
2022
Q3
$289K Hold
5,800
0.02% 241
2022
Q2
$323K Hold
5,800
0.02% 236
2022
Q1
$322K Sell
5,800
-20
-0.3% -$1.03K 0.02% 280
2021
Q4
$326K Sell
5,820
-390
-6% -$21.1K 0.02% 261
2021
Q3
$298K Buy
6,210
+10
+0.2% +$483 0.02% 268
2021
Q2
$260K Sell
6,200
-770
-11% -$29.8K 0.01% 289
2021
Q1
$235K Hold
6,970
0.01% 304
2020
Q4
$243K Sell
6,970
-100
-1% -$3.46K 0.01% 282
2020
Q3
$245K Sell
7,070
-1,010
-13% -$33.7K 0.02% 263
2020
Q2
$265K Sell
8,080
-24,022
-75% -$767K 0.02% 256
2020
Q1
$966K Sell
32,102
-10,710
-25% -$319K 0.09% 139
2019
Q4
$1.24M Buy
+42,812
New +$1.19M 0.08% 174
2016
Q4
Sell
-12,038
Closed -$250K 264
2016
Q3
$250K Buy
12,038
+988
+9% +$24.5K 0.02% 216
2016
Q2
$297K Hold
11,050
0.03% 208
2016
Q1
$299K Sell
11,050
-200
-2% -$5.36K 0.03% 207
2015
Q4
$327K Sell
11,250
-450
-4% -$12.5K 0.04% 196
2015
Q3
$317K Sell
11,700
-1,010
-8% -$28.6K 0.04% 199
2015
Q2
$348K Hold
12,710
0.04% 198
2015
Q1
$339K Sell
12,710
-7,986
-39% -$184K 0.04% 205
2014
Q4
$438K Sell
20,696
-3,358
-14% -$75K 0.05% 178
2014
Q3
$573K Sell
24,054
-1,292
-5% -$29.7K 0.06% 158
2014
Q2
$585K Sell
25,346
-1,628
-6% -$35.9K 0.06% 155
2014
Q1
$616K Buy
26,974
+10,054
+59% +$214K 0.07% 149
2013
Q4
$313K Sell
16,920
-2,740
-14% -$47.8K 0.04% 182
2013
Q3
$333K Buy
19,660
+1,700
+9% +$28.6K 0.04% 175
2013
Q2
$278K Buy
+17,960
New +$299K 0.04% 190

Other funds holding NVO